Cigarette smoking behaviors and time since quitting are associated with differential DNA methylation across the human genome

Human Molecular Genetics

Volumn 21, Issue 13, 2012, Pages 3073-3082

  Wan, Emily S ^a   Qiu, Weiliang ^a   Baccarelli, Andrea ^b   Carey, Vincent J ^a   Bacherman, Helene ^a   Rennard, Stephen I ^c   Agusti, Alvar ^d   Anderson, Wayne ^e   Lomas, David A ^f   Demeo, Dawn L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^d INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^e GLAXOSMITHKLINE   (United States)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR;

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DNA METHYLATION; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN GENOME; HUMAN TISSUE; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PYROSEQUENCING; SMOKING CESSATION;

COHORT STUDIES; CROSS-SECTIONAL STUDIES; DNA METHYLATION; FEMALE; GENOME, HUMAN; HUMANS; MALE; MIDDLE AGED; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PEPTIDE; RECEPTORS, THROMBIN; SMOKING; SMOKING CESSATION;

EID: 84863509978     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/dds135     Document Type: Article

References (70)

1. Mathers, C.D. and Loncar, D. (2006) Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med., 3, e442.
2. Conen, D., Everett, B.M., Kurth, T., Creager, M.A., Buring, J.E., Ridker, P.M. and Pradhan, A.D. (2011) Smoking, smoking status, and risk for symptomatic peripheral artery disease in women: a cohort study. Ann. Intern. Med., 154, 719-726.
3. Kawachi, I., Colditz, G.A., Stampfer, M.J., Willett, W.C., Manson, J.E., Rosner, B., Speizer, F.E. and Hennekens, C.H. (1993) Smoking cessation and decreased risk of stroke in women. JAMA, 269, 232-236.
4. Rea, T.D., Heckbert, S.R., Kaplan, R.C., Smith, N.L., Lemaitre, R.N. and Psaty, B.M. (2002) Smoking status and risk for recurrent coronary events after myocardial infarction. Ann. Intern. Med., 137, 494-500.
5. Bouloukaki, I., Tsiligianni, I.G., Tsoumakidou, M., Mitrouska, I., Prokopakis, E.P., Mavroudi, I., Siafakas, N.M. and Tzanakis, N. (2011) Sputum and nasal lavage lung-specific biomarkers before and after smoking cessation. BMC Pulm. Med., 11, 35.
6. Braber, S., Henricks, P.A., Nijkamp, F.P., Kraneveld, A.D. and Folkerts, G. (2010) Inflammatory changes in the airways of mice caused by cigarette smoke exposure are only partially reversed after smoking cessation. Respir. Res., 11, 99.
7. Louhelainen, N., Stark, H., Mazur, W., Rytila, P., Djukanovic, R. and Kinnula, V.L. (2010) Elevation of sputum matrix metalloproteinase-9 persists up to 6 months after smoking cessation: a research study. BMC Pulm. Med., 10, 13.
8. Vernooy, J.H., Kucukaycan, M., Jacobs, J.A., Chavannes, N.H., Buurman, W.A., Dentener, M.A. and Wouters, E.F. (2002) Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum. Am. J. Respir. Crit. Care Med., 166, 1218-1224.
9. Willemse, B.W., ten Hacken, N.H., Rutgers, B., Lesman-Leegte, I.G., Postma, D.S. and Timens, W. (2005) Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers. Eur. Respir. J., 26, 835-845.
10. Luo, J., Margolis, K.L., Wactawski-Wende, J., Horn, K., Messina, C., Stefanick, M.L., Tindle, H.A., Tong, E. and Rohan, T.E. (2011) Association of active and passive smoking with risk of breast cancer among postmenopausal women: a prospective cohort study. BMJ, 342, d1016.
11. Vineis, P., Alavanja, M., Buffler, P., Fontham, E., Franceschi, S., Gao, Y.T., Gupta, P.C., Hackshaw, A., Matos, E., Samet, J. et al. (2004) Tobacco and cancer: recent epidemiological evidence. J. Natl Cancer Inst., 96, 99-106.
12. Newcomb, P.A. and Carbone, P.P. (1992) The health consequences of smoking. Cancer Med. Clin. North Am., 76, 305-331.
13. Lister, R., Pelizzola, M., Dowen, R.H., Hawkins, R.D., Hon, G., Tonti-Filippini, J., Nery, J.R., Lee, L., Ye, Z., Ngo, Q.M. et al. (2009) Human DNA methylomes at base resolution show widespread epigenomic differences. Nature, 462, 315-322.
14. Breitling, L.P., Yang, R., Korn, B., Burwinkel, B. and Brenner, H. (2011) Tobacco-smoking-related differential DNA methylation: 27K discovery and replication. Am. J. Hum. Genet., 88, 450-457.
15. Breton, C.V., Byun, H.M., Wenten, M., Pan, F., Yang, A. and Gilliland, F.D. (2009) Prenatal tobacco smoke exposure affects global and gene-specific DNA methylation. Am. J. Respir. Crit. Care Med., 180, 462-467.
16. Guerrero-Preston, R., Goldman, L.R., Brebi-Mieville, P., Ili-Gangas, C., Lebron, C., Witter, F.R., Apelberg, B.J., Hernandez-Roystacher, M., Jaffe, A., Halden, R.U. et al. (2010) Global DNA hypomethylation is associated with in utero exposure to cotinine and perfluorinated alkyl compounds. Epigenetics, 5, 539-546.
17. Terry, M.B., Ferris, J.S., Pilsner, R., Flom, J.D., Tehranifar, P., Santella, R.M., Gamble, M.V. and Susser, E. (2008) Genomic DNA methylation among women in a multiethnic New York City birth cohort. Cancer Epidemiol. Biomarkers Prev., 17, 2306-2310.
18. Choi, J.Y., James, S.R., Link, P.A., McCann, S.E., Hong, C.C., Davis, W., Nesline, M.K., Ambrosone, C.B. and Karpf, A.R. (2009) Association between global DNA hypomethylation in leukocytes and risk of breast cancer. Carcinogenesis, 30, 1889-1897.
19. Zhang, F.F., Cardarelli, R., Carroll, J., Fulda, K.G., Kaur, M., Gonzalez, K., Vishwanatha, J.K., Santella, R.M. and Morabia, A. (2011) Significant differences in global genomic DNA methylation by gender and race/ ethnicity in peripheral blood. Epigenetics, 6, 623-629.
20. Hsiung, D.T., Marsit, C.J., Houseman, E.A., Eddy, K., Furniss, C.S., McClean, M.D. and Kelsey, K.T. (2007) Global DNA methylation level in whole blood as a biomarker in head and neck squamous cell carcinoma. Cancer Epidemiol. Biomarkers Prev., 16, 108-114.
21. Moore, L.E., Pfeiffer, R.M., Poscablo, C., Real, F.X., Kogevinas, M., Silverman, D., Garcia-Closas, R., Chanock, S., Tardon, A., Serra, C. et al. (2008) Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case-control study. Lancet Oncol., 9, 359-366.
22. Zhu, Z.Z., Hou, L., Bollati, V., Tarantini, L., Marinelli, B., Cantone, L., Yang, A.S., Vokonas, P., Lissowska, J., Fustinoni, S. et al. (2012) Predictors of global methylation levels in blood DNA of healthy subjects: a combined analysis. Int. J. Epidemiol, 41, 126-139.
23. Ally, M.S., Al-Ghnaniem, R. and Pufulete, M. (2009) The relationship between gene-specific DNA methylation in leukocytes and normal colorectal mucosa in subjects with and without colorectal tumors. Cancer Epidemiol. Biomarkers Prev., 18, 922-928.
24. Belinsky, S.A., Klinge, D.M., Dekker, J.D., Smith, M.W., Bocklage, T.J., Gilliland, F.D., Crowell, R.E., Karp, D.D., Stidley, C.A. and Picchi, M.A. (2005) Gene promoter methylation in plasma and sputum increases with lung cancer risk. Clin. Cancer Res., 11, 6505-6511.
25. Brait, M., Ford, J.G., Papaiahgari, S., Garza, M.A., Lee, J.I., Loyo, M., Maldonado, L., Begum, S., McCaffrey, L., Howerton, M. et al. (2009) Association between lifestyle factors and CpG island methylation in a cancer-free population. Cancer Epidemiol. Biomarkers Prev., 18, 2984-2991.
26. Umemura, S., Fujimoto, N., Hiraki, A., Gemba, K., Takigawa, N., Fujiwara, K., Fujii, M., Umemura, H., Satoh, M., Tabata, M. et al. (2008) Aberrant promoter hypermethylation in serum DNA from patients with silicosis. Carcinogenesis, 29, 1845-1849.
27. Patel, B.D., Coxson, H.O., Pillai, S.G., Agusti, A.G., Calverley, P.M., Donner, C.F., Make, B.J., Muller, N.L., Rennard, S.I., Vestbo, J. et al. (2008) Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med., 178, 500-505.
28. Zhu, G., Warren, L., Aponte, J., Gulsvik, A., Bakke, P., Anderson, W.H., Lomas, D.A., Silverman, E.K. and Pillai, S.G. (2007) The SERPINE2 gene is associated with chronic obstructive pulmonary disease in two large populations. Am. J. Respir. Crit. Care Med., 176, 167-173.
29. Silverman, E.K., Chapman, H.A., Drazen, J.M., Weiss, S.T., Rosner, B., Campbell, E.J., O'Donnell, W.J., Reilly, J.J., Ginns, L., Mentzer, S. et al. (1998) Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis. Am. J. Respir. Crit. Care Med., 157, 1770-1778.
30. Dudek, S.M., Jacobson, J.R., Chiang, E.T., Birukov, K.G., Wang, P., Zhan, X. and Garcia, J.G. (2004) Pulmonary endothelial cell barrier enhancement by sphingosine 1-phosphate: roles for cortactin and myosin light chain kinase. J. Biol. Chem., 279, 24692-24700.
31. Clayburgh, D.R., Rosen, S., Witkowski, E.D., Wang, F., Blair, S., Dudek, S., Garcia, J.G., Alverdy, J.C. and Turner, J.R. (2004) A differentiation-dependent splice variant of myosin light chain kinase, MLCK1, regulates epithelial tight junction permeability. J. Biol. Chem., 279, 55506-55513.
32. Connell, L.E. and Helfman, D.M. (2006) Myosin light chain kinase plays a role in the regulation of epithelial cell survival. J. Cell Sci., 119, 2269-2281.
33. Russo, J.M., Florian, P., Shen, L., Graham, W.V., Tretiakova, M.S., Gitter, A.H., Mrsny, R.J. and Turner, J.R. (2005) Distinct temporal-spatial roles for rho kinase and myosin light chain kinase in epithelial purse-string wound closure. Gastroenterology, 128, 987-1001.
34. Wang, F., Graham, W.V., Wang, Y., Witkowski, E.D., Schwarz, B.T. and Turner, J.R. (2005) Interferon-gamma and tumor necrosis factor-alpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression. Am. J. Pathol., 166, 409-419.
35. Gao, L., Grant, A., Halder, I., Brower, R., Sevransky, J., Maloney, J.P., Moss, M., Shanholtz, C., Yates, C.R., Meduri, G.U. et al. (2006) Novel polymorphisms in the myosin light chain kinase gene confer risk for acute lung injury. Am. J. Respir. Cell Mol. Biol., 34, 487-495.
36. Christie, J.D., Ma, S.F., Aplenc, R., Li, M., Lanken, P.N., Shah, C.V., Fuchs, B., Albelda, S.M., Flores, C. and Garcia, J.G. (2008) Variation in the myosin light chain kinase gene is associated with development of acute lung injury after major trauma. Crit. Care Med., 36, 2794-2800.
37. Flores, C., Ma, S.F., Maresso, K., Ober, C. and Garcia, J.G. (2007) A variant of the myosin light chain kinase gene is associated with severe asthma in African Americans. Genet. Epidemiol., 31, 296-305.
38. Lee, S.O., Cheong, H.S., Park, B.L., Bae, J.S., Sim, W.C., Chun, J.Y., Isbat, M., Uh, S.T., Kim, Y.H., Jang, A.S. et al. (2009) MYLK polymorphism associated with blood eosinophil level among asthmatic patients in a Korean population. Mol. Cells., 27, 175-181.
39. Leguillette, R., Laviolette, M., Bergeron, C., Zitouni, N., Kogut, P., Solway, J., Kachmar, L., Hamid, Q. and Lauzon, A.M. (2009) Myosin, transgelin, and myosin light chain kinase: expression and function in asthma. Am. J. Respir. Crit. Care Med., 179, 194-204.
40. Wang, L., Guo, D.C., Cao, J., Gong, L., Kamm, K.E., Regalado, E., Li, L., Shete, S., He, W.Q., Zhu, M.S. et al. (2010) Mutations in myosin light chain kinase cause familial aortic dissections. Am. J. Hum. Genet., 87, 701-707.
41. Rose, J.E., Behm, F.M., Drgon, T., Johnson, C. and Uhl, G.R. (2010) Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score. Mol. Med., 16, 247-253.
42. Kahn, M.L., Nakanishi-Matsui, M., Shapiro, M.J., Ishihara, H. and Coughlin, S.R. (1999) Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J. Clin. Invest., 103, 879-887.
43. Xu, W.F., Andersen, H., Whitmore, T.E., Presnell, S.R., Yee, D.P., Ching, A., Gilbert, T., Davie, E.W. and Foster, D.C. (1998) Cloning and characterization of human protease-activated receptor 4. Proc. Natl Acad. Sci. USA, 95, 6642-6646.
44. Chen, H.T., Tsou, H.K., Tsai, C.H., Kuo, C.C., Chiang, Y.K., Chang, C.H., Fong, Y.C. and Tang, C.H. (2010) Thrombin enhanced migration and MMPs expression of human chondrosarcoma cells involves PAR receptor signaling pathway. J. Cell Physiol., 223, 737-745.
45. Heiber, M., Marchese, A., Nguyen, T., Heng, H.H., George, S.R. and O'Dowd, B.F. (1996) A novel human gene encoding a G-protein-coupled receptor (GPR15) is located on chromosome 3. Genomics, 32, 462-465.
46. Blaak, H., Boers, P.H., Gruters, R.A., Schuitemaker, H., van der Ende, M.E. and Osterhaus, A.D. (2005) CCR5, GPR15, and CXCR6 are major coreceptors of human immunodeficiency virus type 2 variants isolated from individuals with and without plasma viremia. J. Virol., 79, 1686-1700.
47. Cilliers, T., Willey, S., Sullivan, W.M., Patience, T., Pugach, P., Coetzer, M., Papathanasopoulos, M., Moore, J.P., Trkola, A., Clapham, P. et al. (2005) Use of alternate coreceptors on primary cells by two HIV-1 isolates. Virology, 339, 136-144.
48. Farzan, M., Choe, H., Martin, K., Marcon, L., Hofmann, W., Karlsson, G., Sun, Y., Barrett, P., Marchand, N., Sullivan, N. et al. (1997) Two orphan seven-transmembrane segment receptors which are expressed in CD4-positive cells support simian immunodeficiency virus infection. J. Exp. Med., 186, 405-411.
49. Buttner, P., Mosig, S. and Funke, H. (2007) Gene expression profiles of T lymphocytes are sensitive to the influence of heavy smoking: A pilot study. Immunogenetics, 59, 37-43.
50. Charlesworth, J.C., Curran, J.E., Johnson, M.P., Goring, H.H.H., Dyer, T.D., Diego, V.P., Kent, J.W., Mahaney, M.C., Almasy, L., MacClue, J.W. et al. (2010) Transcriptomic epidemiology of smoking: the effect of smoking on gene expression in lymphocytes. BMC Med. Genomics, 3, 29.
51. Dumeaux, V., Olsen, K.S., Nuel, G., Paulssen, R.H., Borresen-Dale, A.L. and Lund, E. (2010) Deciphering normal blood gene expression variation-the NOWAC postgenome study. PLoS Genet., 6, e1000873.
52. Rotunno, M., Hu, N., Su, H., Wang, C., Goldstein, A.M., Bergen, A.W., Consonni, D., Pesatori, A.C., Bertazzi, P.A., Wacholder, S. et al. (2011) A gene expression signature from peripheral whole blood for stage I lung adenocarcinoma. Cancer Prev. Res. (Phila), 4, 1599-1608.
53. Showe, M.K., Vachani, A., Kossenkov, A.V., Yousef, M., Nichols, C., Nikonova, E.V., Chang, C., Kucharczuk, J., Tran, B., Wakeam, E. et al. (2009) Gene expression profiles in peripheral blood mononuclear cells can distinguish patients with non-small cell lung cancer from patients with nonmalignant lung disease. Cancer. Res., 69, 9202-9210.
54. Landi, M.T., Dracheva, T., Rotunno, M., Figueroa, J.D., Liu, H., Dasgupta, A., Mann, F.E., Fukuoka, J., Hames, M., Bergen, A.W. et al. (2008) Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival. PLoS ONE, 3, e1651.
55. Beane, J., Sebastiani, P., Liu, G., Brody, J.S., Lenburg, M.E. and Spira, A. (2007) Reversible and permanent effects of tobacco smoke exposure on airway epithelial gene expression. Genome Biol, 8, R201.
56. Liu, F., Killian, J.K., Yang, M., Walker, R.L., Hong, J.A., Zhang, M., Davis, S., Zhang, Y., Hussain, M., Xi, S. et al. (2010) Epigenomic alterations and gene expression profiles in respiratory epithelia exposed to cigarette smoke condensate. Oncogene, 29, 3650-3664.
57. Schembri, F., Sridhar, S., Perdomo, C., Gustafson, A.M., Zhang, X., Ergun, A., Lu, J., Liu, G., Bowers, J., Vaziri, C. et al. (2009) MicroRNAs as modulators of smoking-induced gene expression changes in human airway epithelium. Proc. Natl Acad. Sci. USA, 106, 2319-2324.
58. Satta, R., Maloku, E., Zhubi, A., Pibiri, F., Hajos, M., Costa, E. and Guidotti, A. (2008) Nicotine decreases DNA methyltransferase 1 expression and glutamic acid decarboxylase 67 promoter methylation in GABAergic interneurons. Proc. Natl Acad. Sci. USA, 105, 16356-16361.
59. Murray, R.P., Connett, J.E., Lauger, G.G. and Voelker, H.T. (1993) Error in smoking measures: effects of intervention on relations of cotinine and carbon monoxide to self-reported smoking. The Lung Health Study Research Group. Am. J. Public Health, 83, 1251-1257.
60. Patrick, D.L., Cheadle, A., Thompson, D.C., Diehr, P., Koepsell, T. and Kinne, S. (1994) The validity of self-reported smoking: a review and meta-analysis. Am. J. Public Health, 84, 1086-1093.
61. Wagenknecht, L.E., Burke, G.L., Perkins, L.L., Haley, N.J. and Friedman, G.D. (1992) Misclassification of smoking status in the CARDIA study: a comparison of self-report with serum cotinine levels. Am. J. Public Health, 82, 33-36.
62. Bock, C., Tomazou, E.M., Brinkman, A.B., Muller, F., Simmer, F., Gu, H., Jager, N., Gnirke, A., Stunnenberg, H.G. and Meissner, A. (2010) Quantitative comparison of genome-wide DNA methylation mapping technologies. Nat. Biotechnol., 28, 1106-1114.
63. Qiu, W., Baccarelli, A., Carey, V.J., Boutaoui, N., Bacherman, H., Klanderman, B., Rennard, S., Agusti, A., Anderson, W., Lomas, D.A. et al. (2012) Variable DNA methylation is associated with COPD and lung function. Am J Respir Crit Care Med, 185, 373-381.
64. Leek, J.T. and Storey, J.D. (2007) Capturing heterogeneity in gene expression studies by surrogate variable analysis. PLoS Genet., 3, 1724-1735.
65. Leek, J.T. and Storey, J.D. (2008) A general framework for multiple testing dependence. Proc. Natl Acad. Sci. USA, 105, 18718-18723.
66. Breslow, N. and Clayton, D. (1993) Approximate inference in generalized linear mixed models. J. Am. Stat. Assoc., 88, 9-25.
67. Scall, R. (1991) Estimation in generalized linear models with random effects. Biometrika, 78, 719-727.
68. Wolfinger, R. and O'Connell, M. (1993) Generalized linear mixed models: a pseudo-likelihood approach. J. Stat. Comp. Simulat., 48, 233-243.
69. Venables, W.N. and Ripley, B.D. (2002) Modern Applied Statistics with S-PLUS, 4th edn. Springer, New York, NY.
70. Benjamini, Y. and Hochberg, Y. (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. Royal Stat. Soc., 57, 289-300.